Nectar Lifesciences balance sheet

As of Mar 2026

Total assets: ₹622cr−69.6% on Mar 2025
Shareholders' equity: ₹582cr−39.1% on Mar 2025
Total debt: ₹0.0cr−100.0% on Mar 2025
Cash and investments: ₹13.0cr−34.3% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	103	577	590	613
	0.0	56.7	65.7	77.8
	1.1	0.0	0.0	0.0
	0.0	56.5	52.4	49.3
	0.2	0.2	0.2	0.2
	0.1	0.0	0.0	0.0
	0.0	8.5	8.2	7.3
	2.9	3.3	2.8	2.0
	3.2	12.0	11.2	9.5
	224	55.0	7.5	20.6
	0.6	52.8	180	188
	333	810	907	958
	0.3	690	709	673
	13.0	0.5	0.5	0.3
	0.0	345	379	280
	0.0	19.2	19.8	17.6
	112	0.0	0.0	0.0
	0.1	0.9	0.9	0.4
	66.0	7.5	9.2	41.8
	191	374	410	340
	61.5	174	165	219
	253	1,238	1,284	1,231
	35.9	—	0.0	0.0
	622	2,047	2,191	2,189
Equity
	19.4	22.4	22.4	22.4
	563	934	1,047	1,042
	582	956	1,069	1,065
	582	956	1,069	1,065
Liabilities
	0.0	60.1	140	226
	9.2	—	—	0.0
	9.2	60.1	140	226
	0.0	8.7	7.9	6.4
	—	0.7	0.7	0.8
	9.2	69.6	149	234
	0.0	522	495	527
	0.0	438	420	319
	25.7	49.8	38.7	34.4
	25.7	1,010	954	880
	0.0	2.9	2.2	1.9
	0.3	8.8	17.0	8.6
	26.1	1,022	973	891
	4.1	—	0.0	0.0
	39.3	1,091	1,122	1,125
	622	2,047	2,191	2,189
Trade payables — MSME split
	0.0	8.8	—	—
	0.0	429	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

NECLIFE₹10.34

Nectar Lifesciences Limited

· Pharma & Health

₹ CrorePeersAAREYDRUGS NATCAPSUQ MEDICAMEQ MEDICO BALPHARMA ALPA KREBSBIO HALEOSLABSMcap ₹201 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	612.6	590.3	576.6	103.4	103.4
+ Capital Work-in-Progress	77.8	65.7	56.7	0.0	0.0
+ Goodwill	0.0	0.0	0.0	1.1	1.1
+ Other Intangibles	49.3	52.4	56.5	0.0	0.0
+ Non-current Investments	0.2	0.2	0.2	0.2	0.2
+ Long-term Loans	0.0	0.0	0.0	0.1	0.1
+ Trade Receivables — Non-current	7.3	8.2	8.5	0.0	0.0
+ Other Non-current Financial Assets	2.0	2.8	3.3	2.9	2.9
Non-current Financial Assets	9.5	11.2	12.0	3.2	3.2
+ Deferred Tax Assets	20.6	7.5	55.0	224.5	224.5
+ Other Non-current Assets	188.2	180.1	52.8	0.6	0.6
Total Non-current Assets	958.0	907.2	809.6	332.8	332.8
Current Assets
+ Inventories	672.6	709.2	690.2	0.3	0.3
+ Current Investments	0.3	0.5	0.5	13.0	13.0
+ Trade Receivables	279.6	379.2	345.5	0.0	0.0
+ Cash & Cash Equivalents	17.6	19.8	19.2	0.0	0.0
+ Other Bank Balances	0.0	0.0	0.0	112.1	112.1
+ Short-term Loans	0.4	0.9	0.9	0.1	0.1
+ Other Current Financial Assets	41.8	9.2	7.5	66.0	66.0
Current Financial Assets	339.6	409.6	373.6	191.2	191.2
+ Other Current Assets	218.9	165.0	173.8	61.5	61.5
Total Current Assets	1,231.2	1,283.8	1,237.6	253.0	253.0
+ Assets Held for Sale	0.0	0.0	—	35.9	35.9
Total Assets	2,189.2	2,191.1	2,047.2	621.6	621.6
Equity
+ Equity Share Capital	22.4	22.4	22.4	19.4	19.4
+ Other Equity / Reserves	1,042.2	1,046.8	933.7	562.9	562.9
Equity — Owners of Parent	1,064.6	1,069.2	956.1	582.3	582.3
Total Equity	1,064.6	1,069.2	956.1	582.3	582.3
Liabilities
+ Borrowings — Non-current	226.5	140.3	60.1	0.0	0.0
+ Other Non-current Financial Liab	0.0	—	—	9.2	9.2
Non-current Financial Liabilities	226.5	140.3	60.1	9.2	9.2
+ Provisions — Non-current	6.4	7.9	8.7	0.0	0.0
+ Other Non-current Liabilities	0.8	0.7	0.7	—	—
Non-current Liabilities	233.7	149.0	69.6	9.2	9.2
+ Borrowings — Current	527.4	495.2	521.9	0.0	0.0
+ Trade Payables	318.8	419.7	438.1	0.0	0.0
+ Other Current Financial Liab	34.4	38.7	49.8	25.7	25.7
Current Financial Liabilities	880.5	953.6	1,009.8	25.7	25.7
+ Provisions — Current	1.9	2.2	2.9	0.0	0.0
+ Other Current Liabilities	8.6	17.0	8.8	0.3	0.3
Current Liabilities	890.9	972.8	1,021.5	26.1	26.1
+ Liabilities Held for Sale	0.0	0.0	—	4.1	4.1
Total Liabilities	1,124.6	1,121.8	1,091.1	39.3	39.3
Total Equity & Liabilities	2,189.2	2,191.1	2,047.2	621.6	621.6
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	8.8	0.0	0.0
+ Dues to Other Creditors — Current	—	—	429.4	0.0	0.0

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.